Author Archives: Zinnia Jones

About Zinnia Jones

My work focuses on insights to be found across transgender sociology, public health, psychiatry, history of medicine, cognitive science, the social processes of science, transgender feminism, and human rights, taking an analytic approach that intersects these many perspectives and is guided by the lived experiences of transgender people. I live in Orlando with my family, and work mainly in technical writing.

Update on cases of lymphoma linked to textured breast implants in transgender women (BIA-ALCL)

I’ve previously covered emerging findings on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma caused by the textured surfaces of some implants used in breast augmentation surgeries. Textured surfaces have been used in some breast implants to … Continue reading

Posted in Breast, Health care, Oncology, Surgery, Transfeminine | Tagged , | Leave a comment

Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Disclaimer: I am not a medical professional and this is not medical advice. Cyproterone acetate (CPA) … Continue reading

Posted in Endocrinology, Oncology, Progestogens, Transfeminine, Transgender medicine | Tagged , , , | 1 Comment

Once-yearly implanted puberty blockers may last for two years or more

Disclaimer: I am not a medical professional and this is not medical advice. GnRH agonists are a class of medications that reversibly block the progression of natal puberty both in cis youth with precocious (early) puberty and in trans adolescents, … Continue reading

Posted in Endocrinology, Trans youth, Transgender medicine | Tagged , , , , | Leave a comment

Trans women and transfeminine people taking HRT are far less likely to develop prostate cancer

Concerns over supposedly cancer-causing effects of cross-sex hormone therapy are an area in which public alarm has often pulled far ahead of the facts on transition and transgender health. For instance, in 2019, the Telegraph breathlessly reported that the “risk … Continue reading

Posted in Endocrinology, Media, Oncology, Transphobia and prejudice | Tagged , , , , | Leave a comment

Clascoterone, an upcoming topical antiandrogen for acne and hair loss treatment without systemic effects

For trans men, transmasculine and nonbinary people who choose medical transition with testosterone, this treatment can sometimes lead to acne breakouts on the face or body. Testosterone has been found to causes increased skin production of sebum in trans men, … Continue reading

Posted in Dermatology, Endocrinology, Transgender medicine | Tagged , , | Leave a comment